Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 5000 Gulf Fwy #118, Houston, TX 77023, USA
- Website
- cellchorus.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 87 Engineering & Management Services
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Lase Innovation Inc. | Waltham, MA | 334516 Analytical Laboratory Instrument Manufacturing |
| Flexomics LLC | Waltham, MA | — |
| Enrich Biosystems Inc. | Branford, CT | 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) |
| Pumpkinseed Technologies Inc. | Palo Alto, CA | 541713 Research and Development in Nanotechnology |
| Numentus Technologies Inc. | Menlo Park, CA | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
About the company
Cellchorus Inc. is a Houston-based corporate entity specializing in advanced cell analysis technologies, with a focus on developing artificial intelligence-powered platforms for single-cell dynamic imaging and functional characterization. The company operates as a for-profit organization registered in SAM.gov and has demonstrated expertise in creating sophisticated imaging and computational technologies for biomedical research, particularly in the realm of cell therapy and immunological studies. Their core technology, called TIMING (Time-lapse Imaging Microscopy in Nanowell Grids), is an AI-driven platform designed to track and analyze individual cell behaviors with high-throughput capabilities.
The company has secured multiple federal grants from agencies including the National Cancer Institute, National Center for Advancing Translational Sciences, National Science Foundation, and National Institute of General Medical Sciences. These grants, ranging from approximately $399,625 to unspecified amounts, support the development of advanced cell analysis technologies with specific applications in cancer research, cell therapy manufacturing, and immune cell interaction studies. Cellchorus' projects focus on developing sophisticated analytical platforms that can provide detailed insights into cell dynamics, including tracking cell movements, interactions, killing behaviors, proliferative capacities, and metabolic activities. Their research aims to create tools that can help researchers and medical professionals better understand cellular performance, particularly in the context of emerging therapies like CAR T-cell treatments for cancers such as large B cell lymphoma. The grants support the company's efforts to create scalable, high-resolution imaging technologies that can provide unprecedented insights into cellular behavior at the single-cell level.
Quick answers
Is Cellchorus Inc. registered in SAM.gov?
Yes. Cellchorus Inc.'s SAM.gov registration is active through January 7, 2027.
What is Cellchorus Inc.'s CAGE code?
Cellchorus Inc.'s CAGE code is 8V6F5, and its Unique Entity ID (UEI) is LUF6ANBGK7F4.
What is Cellchorus Inc.'s most recent federal award?
Cellchorus Inc.'s most recent federal grant award is Functional signatures of post-infusion car T cells for early indication of patient response - 7. Project… (R43CA298411), from National Cancer Institute (NIH), on September 1, 2025.
On GovTribe
See Cellchorus Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors